PARK SHORE DRUG, INC.
HALLANDALE BEACH, FLORIDA

PARK SHORE DRUG, INC., operating under the brand name Park Shore Pharmacon, is a highly regarded provider in Florida's healthcare sector. Established on November 13, 1958, and incorporated as a Domestic Profit Corporation (DOMP), it is situated at 600 Ansina Boulevard, Hallandale Beach, FL. Over its many years of service, the company specializes in delivering personalized service to meet the specific demands of its clientele. With more than 60 employees and a facility-based operation in Hallandale Beach, PARK SHORE DRUG caters extensively to Florida governmental agencies and distinct special projects. The organization plays a crucial role in supporting long-term care facilities by providing innovative programs crucial for adapting to modern healthcare challenges. Its tailored solutions ensure that these facilities are well-equipped with necessary resources. Further emphasizing its dedication, Park Shore Drug is actively engaged in continuous improvement as reflected in recent updates such as an amended and restated articles/name change on December 27, 2022, along with the submission of its annual report for the year 2024 on February 27, 2024. Guided by experienced leadership, including Robert Gillis as President, Josephine Gillis as Executive, and Steven Propper as Vice President Operations, the company ensures strategic guidance and operational excellence. For more information or to engage their services, PARK SHORE DRUG can be contacted via their official website, parkshoredrug.com.